September 25, 2007 - According to a study published in the October issue of Radiology, researchers using functional magnetic resonance imaging (fMRI) have found a new marker that may aid in early diagnosis of Alzheimer’s disease.

“The findings of this study implicate a potential functional, rather than structural, brain marker—separate from atrophy—that may help enhance diagnosis and treatment monitoring of Alzheimer’s patients,” said the study’s lead author, Jeffrey R. Petrella, M.D., associate professor of radiology at Duke University Medical Center in Durham, N.C.

September 24, 2007 — Integra LifeSciences Holdings Corp. recently announced the release of the OCS2 Ojemann Cortical Stimulator at this week's annual meeting of the Congress of Neurological Surgeons in San Diego, CA.

The OCS2 Ojemann Cortical Stimulator has an FDA clearance in the United States and a CE Mark Certification in the European Union.

September 23, 2007 — Breast cancer survivors who took a weekly dose of risedronate, sold as Actonel, lost significantly less bone than those who did not take the drug, according to a two-year study from the University of Pittsburgh School of Medicine presented this week at the 29th annual meeting of the American Society for Bone and Mineral Research.

September 24, 2007 — Integra LifeSciences Holdings Corp. announced the launch of the Selector SaberTip for the CUSA Selector ultrasonic surgical aspirator system.

The new Selector SaberTip is designed for surgical applications requiring precise and controlled removal of bone and calcified tissues. The Selector SaberTip attaches to the CUSA Selector's 24 kHz neurosurgical short handpiece, offering surgeons market-leading bone-removal power and fine control, and significantly expanding the CUSA Selector system's surgical versatility and utility.

September 24, 2007 – The Society for Molecular Imaging and Nuclear Medicine (SNM) recently reported that based on the results of a recent National Academy of Sciences report, federal funding for basic molecular imaging/nuclear medicine research should be restored to the U.S. Department of Energy.

September 24, 2007 - SonoSite Inc. recently reported that its SonoMB, a new ultrasound technology that incorporates an imaging algorithm that reportedly improves contrast resolution and reduces ultrasound artifact, while providing excellent frame rates and image quality for the clinician, is now available on its curved array probes.

September 21, 2007 - Hologic Inc., a provider of diagnostic imaging and state-of-the-art digital imaging systems directed towards women’s health, recently announced the acquisition of BioLucent Inc., a market leader in its development and sale of its MammoPad breast cushion.

BioLucent, located in Aliso Viejo, California, develops, markets and sells a breast cushion, MammoPad, to decrease the discomfort associated with mammography. BioLucent’s primary research and development efforts are directed at its brachytherapy business which is focused on breast cancer therapy.

September 21, 2007 – To cure the medical profession’s deficiency in the Internet world, a group of doctors has launched a campaign to make it easy and affordable for every doctor to develop a customized Web site.

It’s been a mind-boggling paradox in medicine: Doctors use state-of-the-art equipment and the latest technology to diagnose patients, yet lag well behind almost every other profession when it comes to having Internet sites.

September 21, 2007 — ECRI Institute, an independent nonprofit that researches best approaches to improving patient care, is offering hospitals a one-day pump workshop with support from Massachusetts General Hospital.

Hospital and healthcare system staff will have an opportunity to learn from presenters who will combine clinical considerations, information from medical device evaluations, and guided interaction with devices to teach acquisition strategies. This program builds on the success of past programs to offer attendees best practices.

September 21, 2007 — According to a new survey, the cognitive impairment experienced by 14 to 45 percent of cancer patients can be long-lasting and severely affect their personal and professional lives.

Patients report that the lack of concentration, short-term memory loss, difficulty with word recall and the inability to organize or multi-task have led to significant problems at home and in the workplace.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now